These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical significance of a CYP2D6 poor metabolizer--a patient with schizophrenia on risperidone treatment. Bozina N, Jovanović N, Lovrić M, Medved V. Ther Drug Monit; 2008 Dec; 30(6):748-51. PubMed ID: 18806696 [Abstract] [Full Text] [Related]
23. Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome. Tsai JH, Yang P, Yen JY, Chen CC, Yang MJ. Pharmacotherapy; 2005 Aug; 25(8):1156-9. PubMed ID: 16207109 [Abstract] [Full Text] [Related]
32. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720 [Abstract] [Full Text] [Related]
33. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients. Malempati RN, Bond DJ, Yatham LN. Int Clin Psychopharmacol; 2008 Mar; 23(2):88-94. PubMed ID: 18301123 [Abstract] [Full Text] [Related]
35. Risperidone safety in pregnancy. A case report. Rodríguez-Salgado B. Actas Esp Psiquiatr; 2008 Mar; 36(6):366-8. PubMed ID: 18985459 [Abstract] [Full Text] [Related]
36. Risperidone-induced retrograde ejaculation. Shiloh R, Weizman A, Weizer N, Dorfman-Etrog P, Munitz H. Am J Psychiatry; 2001 Apr; 158(4):650. PubMed ID: 11282707 [No Abstract] [Full Text] [Related]
37. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia. Tamrakar SM, Nepal MK, Koirala NR, Sharma VD, Gurung CK, Adhikari SR. Kathmandu Univ Med J (KUMJ); 2006 Apr; 4(2):152-60. PubMed ID: 18603890 [Abstract] [Full Text] [Related]
38. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Houthoofd SA, Morrens M, Sabbe BG. Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365 [Abstract] [Full Text] [Related]
39. Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. Amiri A, Noorbala AA, Nejatisafa AA, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Hajiazim M, Raznahan M, Akhondzadeh S. Hum Psychopharmacol; 2008 Mar; 23(2):79-86. PubMed ID: 17972359 [Abstract] [Full Text] [Related]
40. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine]. Raignoux C, Dusouchet T, Bret P, Queuille E, Biscay ML, Caron J, Bret MC. Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]